Nemec Sarah: insider trades.
Nemec Sarah reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 1 open-market purchase ($2K) and 3 sales ($26K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 1
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Nemec Sarah
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | Officer · Senior VP, Finance and PAO | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Bolt Biotherapeutics, Inc. | S | 4,077 | $3.24 | 17,082 | Form 4 |
| 2026-09-17 | Bolt Biotherapeutics, Inc. | S | 2,922 | $3.32 | 21,159 | Form 4 |
| 2026-09-16 | Bolt Biotherapeutics, Inc. | S | 843 | $3.77 | 24,081 | Form 4 |
| 2026-06-05 | Bolt Biotherapeutics, Inc. | P | 509 | $3.88 | 1,924 | Form 4 |
Questions
What stock did Nemec Sarah buy or sell?
Nemec Sarah reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 1 open-market purchase ($2K) and 3 sales ($26K), across 1 company.
Is Nemec Sarah the same person as other filers with this name?
This page covers SEC CIK 2023538 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/nemec-sarah-2023538.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.